| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.4M | -16.2% |
| R&D Expense | $4.1M | +33.0% |
| SG&A Expense | $18.2M | -17.4% |
| Operating Income | -$13.8M | +22.3% |
| Interest Expense | $38K | +31.0% |
| Pre-tax Income | -$13.8M | +16.1% |
| Income Tax | -$190K | -2814.3% |
| Net Income | -$13.5M | +17.4% |
| EPS (Basic) | -$0.29 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.6M | -29.3% |
| Accounts Receivable | $6.0M | -33.8% |
| Inventory | $12.0M | +1.1% |
| Current Assets | $44.9M | -24.8% |
| Total Assets | $51.8M | -24.0% |
| Current Liabilities | $6.3M | -30.3% |
| Total Liabilities | $8.1M | -29.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.2M | +3.9% |
| Capital Expenditures | $466K | +131.8% |
| Investing Cash Flow | -$466K | +97.3% |
| Financing Cash Flow | -$958K | -101.6% |
| Free Cash Flow | -$9.7M | +1.1% |
| +23.7% |
| Stockholders' Equity |
| $43.7M |
| -22.9% |